Annual Cash & Cash Equivalents
$28.92 M
-$19.34 M-40.07%
December 31, 2023
Summary
- As of February 8, 2025, CLSD annual cash & cash equivalents is $28.92 million, with the most recent change of -$19.34 million (-40.07%) on December 31, 2023.
- During the last 3 years, CLSD annual cash & cash equivalents has risen by +$11.63 million (+67.29%).
- CLSD annual cash & cash equivalents is now -40.07% below its all-time high of $48.26 million, reached on December 31, 2022.
Performance
CLSD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$13.89 M
-$4.35 M-23.85%
September 30, 2024
Summary
- As of February 8, 2025, CLSD quarterly cash and cash equivalents is $13.89 million, with the most recent change of -$4.35 million (-23.85%) on September 30, 2024.
- Over the past year, CLSD quarterly cash and cash equivalents has dropped by -$14.91 million (-51.78%).
- CLSD quarterly cash and cash equivalents is now -83.63% below its all-time high of $84.83 million, reached on March 31, 2018.
Performance
CLSD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CLSD Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.1% | -51.8% |
| 3 y3 years | +67.3% | -51.8% |
| 5 y5 years | +259.6% | -51.8% |
CLSD Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.1% | at low | -74.0% | at low |
| 5 y | 5-year | -40.1% | +67.3% | -74.0% | at low |
| alltime | all time | -40.1% | +1414.9% | -83.6% | +231.8% |
Clearside Biomedical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.89 M(-23.9%) |
| Jun 2024 | - | $18.24 M(-48.4%) |
| Mar 2024 | - | $35.35 M(+22.3%) |
| Dec 2023 | $28.92 M(-40.1%) | $28.92 M(+0.4%) |
| Sep 2023 | - | $28.80 M(-17.7%) |
| Jun 2023 | - | $35.01 M(-15.5%) |
| Mar 2023 | - | $41.42 M(-14.2%) |
| Dec 2022 | $48.26 M(+58.6%) | $48.26 M(-9.6%) |
| Sep 2022 | - | $53.38 M(+83.9%) |
| Jun 2022 | - | $29.03 M(-15.5%) |
| Mar 2022 | - | $34.37 M(+12.9%) |
| Dec 2021 | $30.44 M(+76.1%) | $30.44 M(+20.7%) |
| Sep 2021 | - | $25.22 M(-4.5%) |
| Jun 2021 | - | $26.41 M(+1.0%) |
| Mar 2021 | - | $26.15 M(+51.3%) |
| Dec 2020 | $17.29 M(-23.5%) | $17.29 M(+16.5%) |
| Sep 2020 | - | $14.84 M(-1.5%) |
| Jun 2020 | - | $15.07 M(-28.0%) |
| Mar 2020 | - | $20.93 M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $22.59 M(+180.9%) | $22.59 M(+0.2%) |
| Sep 2019 | - | $22.55 M(-13.8%) |
| Jun 2019 | - | $26.17 M(-20.6%) |
| Mar 2019 | - | $32.95 M(+309.7%) |
| Dec 2018 | $8.04 M(-12.8%) | $8.04 M(-49.2%) |
| Sep 2018 | - | $15.84 M(-55.0%) |
| Jun 2018 | - | $35.19 M(-58.5%) |
| Mar 2018 | - | $84.83 M(+819.7%) |
| Dec 2017 | $9.22 M(-73.5%) | $9.22 M(-43.4%) |
| Sep 2017 | - | $16.29 M(-2.3%) |
| Jun 2017 | - | $16.68 M(-27.5%) |
| Mar 2017 | - | $22.99 M(-34.0%) |
| Dec 2016 | $34.82 M(+71.7%) | $34.82 M(-5.6%) |
| Sep 2016 | - | $36.88 M(-33.3%) |
| Jun 2016 | - | $55.28 M(+248.0%) |
| Mar 2016 | - | $15.89 M(-21.7%) |
| Dec 2015 | $20.28 M(+145.3%) | $20.28 M(+384.5%) |
| Sep 2015 | - | $4.19 M(-49.4%) |
| Dec 2014 | $8.27 M(+333.2%) | $8.27 M |
| Dec 2013 | $1.91 M | - |
FAQ
- What is Clearside Biomedical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Clearside Biomedical?
- What is Clearside Biomedical annual cash & cash equivalents year-on-year change?
- What is Clearside Biomedical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Clearside Biomedical?
- What is Clearside Biomedical quarterly cash and cash equivalents year-on-year change?
What is Clearside Biomedical annual cash & cash equivalents?
The current annual cash & cash equivalents of CLSD is $28.92 M
What is the all time high annual cash & cash equivalents for Clearside Biomedical?
Clearside Biomedical all-time high annual cash & cash equivalents is $48.26 M
What is Clearside Biomedical annual cash & cash equivalents year-on-year change?
Over the past year, CLSD annual cash & cash equivalents has changed by -$19.34 M (-40.07%)
What is Clearside Biomedical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CLSD is $13.89 M
What is the all time high quarterly cash and cash equivalents for Clearside Biomedical?
Clearside Biomedical all-time high quarterly cash and cash equivalents is $84.83 M
What is Clearside Biomedical quarterly cash and cash equivalents year-on-year change?
Over the past year, CLSD quarterly cash and cash equivalents has changed by -$14.91 M (-51.78%)